2nd International Conference on Immune-Mediated Diseases & 8th International Anti-Inflammation Meeting

By Braddock Martin  

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 5, 2004-05 ,pp. : 555-564

Informa Healthcare

Access to resources Recommend Favorite

Genomic variation in the MAP3K5 gene is associated with &bgr;-thalassemia disease severity and hydroxyurea treatment efficacy

By Tafrali Christina   Paizi Arsinoi   Borg Joseph   Radmilovic Milena   Bartsakoulia Marina   Giannopoulou Emily   Giannakopoulou Olga   Stojiljkovic-Petrovic Maja   Zukic Branka   Poulas Konstantinos   Stavrou Eleana F   Lambropoulou Polyxeni   Kourakli Alexandra   Felice Alexander E   Papachatzopoulou Adamantia   Philipsen Sjaak   Pavlovic Sonja   Georgitsi Marianthi   Patrinos George P  

Pharmacogenomics, Vol. 14, Iss. 5, 2013-04 ,pp. : 469-483

Future Medicine

Access to resources Recommend Favorite

Iron Chelators for the Treatment of Cancer

By  

Current Medicinal Chemistry, Vol. 19, Iss. 17, 2012-06 ,pp. : 2689-2702

Bentham Science Publishers

Access to resources Recommend Favorite

The Medicinal Chemistry of Novel Iron Chelators for the Treatment of Cancer

By  

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 5, 2011-01 ,pp. : 483-499

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic efficacy of different iron chelators in Egyptian children with Beta Thalassemia with iron overload

By  

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 15, Iss. 2, 2015-01 ,pp. : 98-105

Bentham Science Publishers

Access to resources Recommend Favorite